Remdesivir was originally developed to treat Ebola, and a number of studies have shown it stops SARS and MERS, which are the viral cousins of COVID-19.
TUESDAY, April 21, 2020 (HealthDay News) -- Preliminary data from two clinical trials using the antiviral drug remdesivir to treat COVID-19 patients is encouraging, researchers report.
One trial is providing the drug to patients with moderate illness and the other focuses on patients with severe illness.
A number of the patients are now recovering and have been released from the hospital. While it's too early to tell, the researchers said there are also indications that remdesivir can possibly stave off being put on a ventilator.